Frazier Life Sciences Public Fund, L.P. 13D/13G Filings for Eledon Pharmaceuticals, Inc. (ELDN)

Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Eledon Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-05
11:44 am
Purchase
2024-10-3013GEledon Pharmaceuticals, Inc.
ELDN
Frazier Life Sciences Public Fund, L.P. 3,561,644
6.100%
3,561,644increase
(New Position)
Filing